COVID-19 and Gastrointestinal Disease: Current Insights and Future Management

COVID-19 is the most prominent and rapidly evolving public health concern in the world currently. The gastrointestinal manifestations of COVID-19 are increasingly being recognized. SARS-CoV-2 infection has been associated with the occurrence of nausea, vomiting, and diarrhea. SARS-CoV-2 has also bee...

Full description

Saved in:
Bibliographic Details
Other Authors: Goyal, Hemant (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_95822
005 20230105
003 oapen
006 m o d
007 cr|mn|---annan
008 20230105s2022 xx |||||o ||| 0|eng d
020 |a books978-3-0365-6090-8 
020 |a 9783036560892 
020 |a 9783036560908 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-6090-8  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Goyal, Hemant  |4 edt 
700 1 |a Goyal, Hemant  |4 oth 
245 1 0 |a COVID-19 and Gastrointestinal Disease: Current Insights and Future Management 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (184 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a COVID-19 is the most prominent and rapidly evolving public health concern in the world currently. The gastrointestinal manifestations of COVID-19 are increasingly being recognized. SARS-CoV-2 infection has been associated with the occurrence of nausea, vomiting, and diarrhea. SARS-CoV-2 has also been causing pancreatic and hepatic injury. Emerging data have shown that COVID-19 patients continue to shed the virus into their stools, even when patients test negative for COVID-19 in pulmonary secretions. However, the epidemiology, pathogenesis, and treatment of SARS-CoV-2-related gastrointestinal manifestations are poorly understood. The pandemic has also had a significant impact on gastroenterologists, endoscopists, and other ancillary staff. Moreover, in the past, systematic respiratory virus syndrome (SARS) was shown to be transmitted by endoscopes, which is a big concern with COVID-19, as it shares many pathological features with SARS. The deferral of elective endoscopic procedures has negatively affected gastroenterologists. This Special Issue focuses on the current situation of this pandemic. It aims to provide insight into the gastrointestinal manifestations of COVID-19 and its effects on endoscopic procedures. I believe that this issue will be beneficial not only for gastroenterologists but also other healthcare workers around the world to recognize the often-ignored clinical gastrointestinal manifestations of COVID-19. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a COVID-19 
653 |a liver 
653 |a non-alcoholic steatohepatitis 
653 |a transient elastography 
653 |a mortality 
653 |a liver disease 
653 |a clinical manifestations 
653 |a SARS-CoV-2 
653 |a gastroenterology 
653 |a hepatology 
653 |a endoscopy 
653 |a delivery of healthcare 
653 |a acute mesenteric ischemia 
653 |a thromboemboembolism 
653 |a endothelitis 
653 |a cytokines 
653 |a hypercoagulability 
653 |a inflammatory bowel disease 
653 |a gastrointestinal manifestations 
653 |a abdominal pain 
653 |a dyspnea 
653 |a clinical course 
653 |a upper gastrointestinal bleeding 
653 |a pandemic 
653 |a outcomes 
653 |a anxiety 
653 |a depression 
653 |a medication adherence 
653 |a severity of COVID-19 
653 |a hospitalized patients 
653 |a risk factors 
653 |a SARS-CoV-2 infection 
653 |a gut dysbiosis 
653 |a microbiota 
653 |a gastrointestinal disorders 
653 |a intestinal inflammation 
653 |a ACE2 dysregulation 
653 |a gut microbiota 
653 |a enteric infection 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/6478  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/95822  |7 0  |z DOAB: description of the publication